Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies. (Q41509275)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9195603%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9195603%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9195603%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Christopher G. Parsons

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9195603%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1

W Danysz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9195603%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

W J Schmidt

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9195603%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

G Quack

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9195603%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

1 reference

1 July 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9195603%20AND%20SRC:MED&resulttype=core&format=json

Neuroscience & Biobehavioral Reviews

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9195603%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9195603%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

455-468

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9195603%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9195603%20AND%20SRC:MED&resulttype=core&format=json

Clinical pharmacokinetics of amantadine hydrochloride.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Amantadine kinetics in healthy young subjects after long-term dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Anticonvulsant effects of memantine and MK-801 in guinea pig hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Amantadine sulphate in treating Parkinson's disease: clinical effects, psychometric tests and serum concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Different binding affinities of NMDA receptor channel blockers in various brain regions—Indication of NMDA receptor heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Studies on the mechanism of action of amantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

2,4,5-Trihydroxyphenylalanine (6-hydroxy-DOPA) displaces [3H]AMPA binding in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

The time course of glutamate in the synaptic cleft

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

The 6-hydroxydopamine rotational model for the detection of dopamine agonist activity: reliability of effect from different locations of 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Glutamate antagonists have different effects on spontaneous locomotor activity in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats?--case of amantadine and memantine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Dizocilpine (MK-801), ketamine and phencyclidine: low doses affect brain field potentials in the freely moving rat in the same way as activation of dopaminergic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Radioelectroencephalographic comparison of memantine with receptor-specific drugs acting on dopaminergic transmission in freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Pharmacological activity of amantadine: effect of N-alkyl substitution.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Amantadine treatment of a patient with anoxic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Neurotransmitter glutamate: its clinical importance.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

The effect of adding amantadine to optimum L-dopa dosage in Parkinson's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

N-Methyl-d-Aspartate Antagonists in the Treatment of Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

The effect of dimethylaminoadamantane on neuronal membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

The NMDA antagonist dizocilpine (MK-801) reverses haloperidol-induced movement initiation deficits.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Evaluation of amantadine as a releasing agent or uptake blocker for H3-dopamine in rat brain slices

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Structure-anti-Parkinson activity relationships in the aminoadamantanes. Influence of bridgehead substitution

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Evidence for lysosomotropism of memantine in cultured human cells: cellular kinetics and effects of memantine on phospholipid content and composition, membrane fluidity and beta-adrenergic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Membrane properties and synaptic responses of rat striatal neurones in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Amantadine and D-145, an amantadine derivative, do not effect dopamine sensitive adenylate cyclase from the caudate-putamen of the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Multiple structural determinants of voltage-dependent magnesium block in recombinant NMDA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Memantine prevents quinolinic acid-induced hippocampal damage

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Therapeutic brain concentration of the NMDA receptor antagonist amantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Affinity of 1-aminoadamantanes for the σ binding site in post-mortem human frontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

The effect of amantadine and (+)-amphetamine on motility in rats after inhibition of monoamine synthesis and storage

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Antiparkinsonian drugs and in vitro excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

The effect of amantadine on motor activity and catalepsy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Effects of memantine on the frog neuromuscular junction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

GABA-ergic drugs block the locomotor stimulant effects of 1,3-dimethyl-5-aminoadamantane (D-145)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Pharmacological evidence for the involvement of GABA-ergic system in the locomotor stimulation produced in mice by 1,3-dimethyl-5-aminoadamantane (D-145)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Evidence for presynaptic antagonism by amantadine of indirectly acting central stimulants

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Effect of amantadine on chlorpromazine and reserpine-induced behavioral depression in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Modulation of NMDA effects on agonist-stimulated phosphoinositide turnover by memantine in neonatal rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Learning deficits induced by chronic intraventricular infusion of quinolinic acid--protection by MK-801 and memantine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Amantadine increases the extracellular dopamine levels in the striatum by re-uptake inhibition and by N-methyl-D-aspartate antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Potential antidepressive properties of amantadine, memantine and bifemelane

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

NMDA receptor subtype selectivity: eliprodil, polyamine spider toxins, dextromethorphan, and desipramine selectively block NMDA-evoked striatal acetylcholine but not spermidine release

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

The clinically available NMDA receptor antagonist memantine is antinociceptive on rat spinal neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Memantine stimulates inositol phosphates production in neurones and nullifies N-methyl-D-aspartate-induced destruction of retinal neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

The role of excitatory amino acids in experimental models of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Amantadine may stimulate dopamine and noradrenaline receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Memantine (1-amino-3,5-dimethyladamantane) blocks the serotonin-induced depolarization response in a neuronal cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Memantine inhibits serotonin-induced rise of cytosolic Ca2+ activity and of cyclic GMP level in a neuronal cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Suppression by memantine and amantadine of synaptic excitation intrastriatally evoked in rat neostriatal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Anticataleptic potencies of glutamate-antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

[Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study]

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Amantadine in the Treatment of Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

N-methyl-D-aspartate (NMDA)-mediated muscle relaxant action of memantine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat--a pharmacokinetic microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Locomotor effects of amantadine in the mouse are not those of a typical glutamate antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Intranigral but not intrastriatal microinjection of the NMDA antagonist MK-801 induces contralateral circling in the 6-OHDA rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Further Studies on the Mode of Action of Amantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Amantadine induces c-fos in rat striatum: reversal with dopamine D1 and NMDA receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Effects of memantine on the twitch tension of mouse diaphragm.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Amantadine treatment is an independent predictor of improved survival in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Interaction of memantine with cholecystokinin receptors in mouse brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy- piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Excitatory Amino Acid Transmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Elevated NMDA receptors in parkinsonian striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amantadine and memantine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

The effects of mitochondrial failure upon cholinergic toxicity in the nucleus basalis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

1 reference

7 January 2021

Anticataleptic actions of amantadine hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900037-1

7 January 2021

10.1016/S0149-7634(96)00037-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9195603%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference